Mayo Clinic

Hospital


Location: Rochester, MN, United States (USA) (US) US

ISNI: 000000040459167X

ROR: https://ror.org/02qp3tb03

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease (2024) Ramachandran D, Tyrer JP, Kommoss S, DeFazio A, Riggan MJ, Webb PM, Fasching P, et al. Journal article Bi-allelic variants in CELSR3 are implicated in central nervous system and urinary tract anomalies (2024) Stegmann JD, Kalanithy JC, Dworschak GC, Ishorst N, Mingardo E, Lopes FM, Ho YM, et al. Journal article Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer (2024) Fasching P, Hu C, Hart SN, Rübner M, Polley EC, Gnanaolivu RD, Hartkopf AD, et al. Journal article Letter to the Editor: Announcement of a Call for Proposals for biomedical waveform coding (2024) Halford JJ, Campobello G, Brinkmann BH, Stead M, Rampp S, Rémi J, Nilsen KB, et al. Journal article Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma (2024) Saner FA, Takahashi K, Budden T, Pandey A, Ariyaratne D, Zwimpfer TA, Meagher NS, et al. Journal article The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD (2024) DeFilipp Z, Kim HT, Spyrou N, Katsivelos N, Kowalyk S, Eng G, Kasikis S, et al. Journal article 177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study (2024) Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel ME, Kunz PL, Chasen B, et al. Journal article Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD (2024) Etra A, Jurdi NE, Katsivelos N, Kwon D, Gergoudis S, Morales G, Spyrou N, et al. Journal article Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group (2024) Shumnalieva R, Ravichandran N, Hannah J, Javaid M, Darooka N, Roy D, Gonzalez DE, et al. Journal article Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges (2024) Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, et al. Journal article